PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

GI Monitor, Leading (IBD) Crohn's and Colitis Mobile Tracking App from WellApps, Upgrades User-base and Platform as Creator Recovers from Surgery

GI Monitor, available for iOS, Android and web-enabled devices, quadruples user-base and adds patient comparisons as the app's creator recovers from having his colon removed.

2011-06-14
UPPER SADDLE RIVER, NJ, June 14, 2011 (Press-News.org) WellApps, Inc. announced today the newest release of GI Monitor, its symptom tracking app for (IBD) Crohn's and Ulcerative Colitis. Co-Founder Edward Shin, MD, says, "We're particularly excited about the new release since GI Monitor has recently quadrupled its user-base. This scale is providing some powerful real-time data and we know what an engaged mobile community can mean for patients." One of those patients is Brett Shamosh, creator of GI Monitor and Co-Founder of WellApps, who has a personal passion for the potential of mobile health. After twenty years with Ulcerative Colitis, Brett chose to undergo a colectomy to prevent colon cancer and is recovering in the hospital as GI Monitor's newest features are being released. "Removing my colon was a very tough decision and I wanted to have more data at my fingertips when I made it. I'm hopeful that emerging mobile communication technologies will lead to better-informed decisions and improved quality of life."

GI Monitor allows (IBD), Crohn's and Colitis patients to easily track symptoms, share reports with their doctors and use interactive charts to make correlations between symptoms, diet and medications. The newest release includes an updated web-app that allows patients to compare their symptoms and medications to the averages within their diagnosis. Another new feature of the mobile apps is called "Photo Therapy", which encourages users to share photos of things that make them smile.

GI Monitor is free to patients and is currently available in the iTunes Store, Android Market and at http://www.wellapps.com.

WellApps develops and distributes symptom tracking applications for patients with chronic illnesses. The data collected is compiled into easy-to-read reports for physicians, resulting in optimal patient treatment and reduced periods of active disease. Patients can also access interactive charts to see correlations between symptoms and understand how compliance to medication affects their well-being. De-identified data from our patient population is collected anonymously and shared with researchers to make progress in the treatment of chronic illnesses.

For more information: support@wellapps.com


ELSE PRESS RELEASES FROM THIS DATE:

Birdsong independent of brain size

Birdsong independent of brain size
2011-06-14
The brains of all vertebrates display gender-related differences. In songbirds, for example, the size of the brain areas that control their singing behaviour could be linked to the size of their song repertoires. In many songbird species, only the males sing and indeed, they do have larger song control areas in the brain than females. However, even species where both sexes sing identically, display the same sex differences in their brain structure. Researchers at the Max Planck Institute for Ornithology in Seewiesen have now demonstrated for the first time in the white-browed ...

Oral appliance therapy improves craniofacial growth direction and snoring

2011-06-14
DARIEN, Ill. – According to new research that will be presented Saturday, June 11, at the 20th Anniversary Meeting of the American Academy of Dental Sleep Medicine (AADSM), children with enlarged tonsils and adenoids who wore an oral appliance for six months experienced more favorable craniofacial growth, enlargement of pharyngeal dimensions, and improved breathing and snoring during sleep. Enlarged tonsils and dental malocclusion have a strong relation with sleep disturbance in children. Its consequences can include abnormalities of craniofacial growth and facial morphology ...

Study finds excellent agreement between subjective and objective compliance with OAT

2011-06-14
DARIEN, Ill. – According to new research that will be presented Saturday, June 11, at the 20th Anniversary Meeting of the American Academy of Dental Sleep Medicine (AADSM), objective compliance measurements agree with subjective compliance estimates in patients with obstructive sleep apnea (OSA) undergoing oral appliance therapy (OAT) – a finding that is not apparent in patients using continuous positive airway pressure (CPAP) therapy. Results show that the objective mean wearing time in the whole group was 6.8 hours per night. Among 21 patients who filled out the subjective ...

Study finds that combination therapy reduces pauses in breathing caused by OSA

2011-06-14
DARIEN, Ill. – According to new research that will be presented Saturday, June 11, at the 20th Anniversary Meeting of the American Academy of Dental Sleep Medicine (AADSM), the apnea-hypopnea index (AHI) in patients with severe obstructive sleep apnea (OSA) was more improved by a combination treatment of a mandibular advancement splint (MAS) and positive airway pressure (PAP) therapy than by continuous positive airway pressure (CPAP) therapy alone. Results show that without lowering the pressure substantially, CPAP tolerance can be improved and severe OSA can be effectively ...

Novel device quantifies the efficacy of oral appliance therapy for snoring and sleep apnea

2011-06-14
DARIEN, Ill. – New research that will be presented Saturday, June 11, at the 20th Anniversary Meeting of the American Academy of Dental Sleep Medicine (AADSM) in Minneapolis, Minn., quantified the efficacy of mandibular advancement splints (MAS) using a self-administered, at-home device to monitor snoring and sleep-disordered breathing. Clinical assessment of MAS efficacy in the treatment of snoring and obstructive sleep apnea (OSA) is based predominantly on subjective reports by the patient and partner, and less commonly, on the apnea hypopnea index (AHI), which is ...

UCL grows first telecommunications wavelength quantum dot laser on a silicon substrate

2011-06-14
A new generation of high speed, silicon-based information technology has been brought a step closer by researchers in the Department of Electronic and Electrical Engineering at UCL and the London Centre for Nanotechnology. The team's research, published in next week's Nature Photonics journal, provides the first demonstration of an electrically driven, quantum dot laser grown directly on a silicon substrate (Si) with a wavelength (1300-nm) suitable for use in telecommunications. Silicon is the most widely used material for the fabrication of active devices in electronics. ...

Heart attack death rates linked to ambulance diversion

2011-06-14
Heart attack patients die at a higher rate when their nearest emergency room is so overtaxed that the ambulance transporting them is dispatched to another hospital, according to a new study led by scientists at the University of California, San Francisco. The findings will be published online June 12, 2011 by JAMA, the Journal of the American Medical Association. The research also will be presented on June 13, 2011 at the AcademyHealth's annual research meeting in Seattle, WA. "This is one of the first studies to tie patient-level outcomes to daily ambulance diversion ...

Aurora A may contribute to kidney disease

Aurora A may contribute to kidney disease
2011-06-14
The Aurora A kinase may contribute to polycystic kidney disease (PKD) by inactivating a key calcium channel in kidney cells, according to a study in the June 13 issue of The Journal of Cell Biology (www.jcb.org). Aurora A is an oncogene best known as a regulator of mitotic progression. But the kinase has important functions during interphase as well, when it can promote cilia disassembly and can be activated by elevated calcium levels. Because both calcium signaling and cilia are defective in PKD, researchers from the Fox Chase Cancer Center in Philadelphia wondered whether ...

High rates of injection drug use in urban Aboriginal youth signal need for prevention programs

2011-06-14
A new study indicates high rates of injection drug use in urban Canadian Aboriginal youth, particularly in women, and points to the need for culturally specific prevention programs, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101257.pdf Aboriginal leadership is alarmed at the levels of substance abuse in their young people, especially injection drug use, which is associated with HIV and hepatitis C virus infections. Injection drug use accounts for 70%󈞼% of all hepatitis C virus and almost ...

Health data can help address alcohol-related harm in youth

2011-06-14
Administrative information can be useful for surveillance and understanding of alcohol-related harm in young people, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj110367.pdf Binge drinking and overconsumption of alcohol by young people is a growing issue in many countries. For example, in a 2009 study, almost 60% of young Canadians aged 15-24 reported having consumed alcohol in the previous month, with 22% reporting heaving drinking and 20% experiencing harm related to alcohol consumption. In Australia, ...

LAST 30 PRESS RELEASES:

Recycled plastics can affect hormone systems and metabolism

How babies are affected by their mother’s age

‘Closed loop’ learning barriers prevent doctors from using life-saving bedside ultrasound

Simple blood test predicts cognitive decline in Alzheimer's patients, new study shows

Antimicrobial resistance genes hitch rides on imported seafood

New way to find “aged” cells marks fresh approach for research into ageing

From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency

Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows

New method to study catalysts could lead to better batteries

Current Molecular Pharmacology impact factor rises to 2.9, achieving Q2 ranking in the Pharmacology & Pharmacy category in 2024 JCR

More time with loved ones for cancer patients spared radiation treatment

New methods speed diagnosis of rare genetic disease

Genetics of cardiomyopathy risk in cancer survivors differ by age of onset

Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism

Targeting fusion protein’s role in childhood leukemia produces striking results

Clear understanding of social connections propels strivers up the social ladder

New research reveals why acute and chronic pain are so different – and what might make pain last

Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming

New research casts doubt on ancient drying of northern Africa’s climate

Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns

AI development: seeking consistency in logical structures

Want better sleep for your tween? Start with their screens

Cancer burden in neighborhoods with greater racial diversity and environmental burden

Alzheimer disease in breast cancer survivors

New method revolutionizes beta-blocker production process

Mechanism behind life-threatening cancer drug side-effect revealed

Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive

Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments

Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies

Exercise-induced protein revives aging muscles and bones

[Press-News.org] GI Monitor, Leading (IBD) Crohn's and Colitis Mobile Tracking App from WellApps, Upgrades User-base and Platform as Creator Recovers from Surgery
GI Monitor, available for iOS, Android and web-enabled devices, quadruples user-base and adds patient comparisons as the app's creator recovers from having his colon removed.